AstraZeneca and Serum Institute of India’s COVID-19 Vaccine Receive WHO’s EUA to Prevent COVID-19

February 16, 2021 Auto Bot AstraZeneca, EUA, Prevent, Receive, regulatory, Serum Institute of India, Vaccine, WHO 0

Shots:

  • WHO has granted EUL to AZ’s vaccine for active immunization to prevent COVID-19 in individuals aged ≥18yrs., including those over 65yrs. EUL granted AZ and SII enabling global access to the vaccine
  • The WHO’s SAGE recommended a dosing interval of 8-12wks. and also recommended the use of the vaccine in countries where new variants, including the South African B1.351 variant, are prevalent
  • AZ & SII will work with the COVAX Facility to begin the supply of vaccine across the globe and will be allocated equitably according to the COVAX Allocation Framework

Click here ­to­ read full press release/ article | Ref: AstraZeneca | Image: AstraZeneca

The post AstraZeneca and Serum Institute of India’s COVID-19 Vaccine Receive WHO’s EUA to Prevent COVID-19 first appeared on PharmaShots.